Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of EA201990404A1publicationCriticalpatent/EA201990404A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Настоящее изобретение относится к твердофазным формам соли п-толуолсульфоновой кислоты (ПТСК) селективного ингибитора PI3K-дельта (S)-2-(1-(4-амино-3-(3-фтор-4-изопропоксифенил)-1H-пиразоло[3,4-d]пиримидин-1-ил)этил)-3-(3-фторфенил)-4H-хромен-4-она (TGR-1202). Настоящее изобретение также относится к способам получения указанных соединений, содержащим их фармацевтическим композициям и способам лечения опосредованных киназой PI3K (фосфатидилинозитол-3-киназой) болезней или расстройств, таких как рак, путем их введения.The present invention relates to solid-phase forms of a salt of p-toluenesulfonic acid (PTSK) of a selective inhibitor of PI3K-delta (S) -2- (1- (4-amino-3- (3-fluoro-4-isopropoxyphenyl) -1H-pyrazolo [3 , 4-d] pyrimidin-1-yl) ethyl) -3- (3-fluorophenyl) -4H-chromen-4-one (TGR-1202). The present invention also relates to methods for producing said compounds, pharmaceutical compositions containing them and methods for treating PI3K kinase (phosphatidylinositol-3-kinase) mediated diseases or disorders, such as cancer, by administering them.
EA201990404A2014-05-272015-05-26
IMPROVED FORMS OF THE SELECTIVE PI3K DELTA INHIBITOR FOR APPLICATION IN PHARMACEUTICALS
EA201990404A1
(en)
3-SUBSTITUTED DERIVATIVES ESTRA-1,3,5 (10), 16-TETRAENA, METHODS OF THEIR PRODUCTION, PHARMACEUTICAL MEANS, WHICH CONTAIN THEM, AND THEIR USE FOR RECEPTION OF MEDICINES